Firefly Neuroscience (AIFF) Amortization of Deferred Charges (2021 - 2025)

Firefly Neuroscience's Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $126000.0 for Q1 2025.

• On a quarterly basis, Amortization of Deferred Charges changed N/A year-over-year to $126000.0 in Q1 2025; TTM through Dec 2025 was $126000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $126000.0, changed N/A from the prior year.
• Amortization of Deferred Charges grew to $126000.0 in Q1 2025 per AIFF's latest filing, from $33563.0 in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $566839.0 in Q4 2021 and bottomed at -$191563.0 in Q3 2021.
• The 4-year median for Amortization of Deferred Charges is $44919.0 (2022), against an average of $81622.8.
• Biggest YoY gain for Amortization of Deferred Charges was 124.04% in 2022; the steepest drop was 91.77% in 2022.
• Year by year, Amortization of Deferred Charges stood at $566839.0 in 2021, then sank by 91.77% to $46629.0 in 2022, then decreased by 28.02% to $33563.0 in 2023, then surged by 275.41% to $126000.0 in 2025.
• Per Business Quant, the three latest AIFF Amortization of Deferred Charges figures stand at $126000.0 (Q1 2025), $33563.0 (Q4 2023), and $32934.0 (Q3 2023).